naproxen has been researched along with phenothiazine in 3 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (phenothiazine) | Trials (phenothiazine) | Recent Studies (post-2010) (phenothiazine) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 2,553 | 7 | 191 |
| Protein | Taxonomy | naproxen (IC50) | phenothiazine (IC50) |
|---|---|---|---|
| NADPH oxidase 1 | Homo sapiens (human) | 0.3589 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 18.5 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.236 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.016 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.461 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 1.4 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 4.643 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.592 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.196 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.461 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.236 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.532 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.94 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.94 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carty, TJ; Moore, PF; Mylari, BL; Zembrowski, WJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
3 other study(ies) available for naproxen and phenothiazine
| Article | Year |
|---|---|
1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Cell Line; Cyclooxygenase Inhibitors; Edema; Indicators and Reagents; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Models, Molecular; Molecular Structure; Prostaglandin Antagonists; Pyrroles; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thiazines | 1990 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |